Review
Neuronal ceroid lipofuscinoses therapeutic strategies: Past, present and future

https://doi.org/10.1016/j.bbadis.2006.08.004Get rights and content
Under an Elsevier user license
open archive

Abstract

Historically, many different therapies have been assessed for their ability to alter disease progression of the Neuronal Ceroid Lipofuscinoses (NCLs). While some treatments have lead to minor improvements, none have been able to arrest disease progression or improve the quality or duration of life. Presently, many new therapeutic strategies, such as chaperone therapy, enzyme replacement therapy, gene therapy, and stem cell therapy, are being investigated for their ability to alter the disease course of the NCLs. This review summarizes previous studied therapies, discusses those currently being evaluated and examines possibilities for future therapies for the treatment of patients with NCL.

Keywords

Neuronal ceroid lipofuscinoses
Chemical chaperone therapy
Enzyme therapy
Stem cell therapy
Gene therapy

Cited by (0)